OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Bio‐Hermes Study: Biomarker database developed to investigate blood‐based and digital biomarkers in community‐based, diverse populations clinically screened for Alzheimer's disease
Richard C. Mohs, Douglas W. Beauregard, John Dwyer, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 4, pp. 2752-2765
Open Access | Times Cited: 18
Richard C. Mohs, Douglas W. Beauregard, John Dwyer, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 4, pp. 2752-2765
Open Access | Times Cited: 18
Showing 18 citing articles:
Alzheimer’s disease biomarkers and their current use in clinical research and practice
T. Hunter, Luís E. Santos, Fernanda Tovar‐Moll, et al.
Molecular Psychiatry (2024)
Closed Access | Times Cited: 7
T. Hunter, Luís E. Santos, Fernanda Tovar‐Moll, et al.
Molecular Psychiatry (2024)
Closed Access | Times Cited: 7
Effect of long-term physical exercise and multidomain interventions on cognitive function and the risk of mild cognitive impairment and dementia in older adults: a systematic review with meta-analysis
Imanol Reparaz‐Escudero, Míkel Izquierdo, Heike A. Bischoff‐Ferrari, et al.
Ageing Research Reviews (2024) Vol. 100, pp. 102463-102463
Closed Access | Times Cited: 6
Imanol Reparaz‐Escudero, Míkel Izquierdo, Heike A. Bischoff‐Ferrari, et al.
Ageing Research Reviews (2024) Vol. 100, pp. 102463-102463
Closed Access | Times Cited: 6
Cognivue Clarity® characterizes amyloid status and preclinical Alzheimer's disease in biomarker confirmed cohorts in the Bio-Hermes Study
James E. Galvin, Michael J. Kleiman, Paul W. Estes, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
James E. Galvin, Michael J. Kleiman, Paul W. Estes, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Diagnostic and discriminative accuracy of plasma phosphorylated tau 217 for symptomatic Alzheimerʼs disease in a Chinese cohort
Limin Li, Ping Che, Dequan Liu, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100092-100092
Open Access
Limin Li, Ping Che, Dequan Liu, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100092-100092
Open Access
Influence of cognitive impairment and race on plasma p‐Tau217 in two diverse cohorts
Ashima Nayyar, Mei‐Ling Li, Victor Sotelo, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 2
Open Access
Ashima Nayyar, Mei‐Ling Li, Victor Sotelo, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 2
Open Access
Cognitive Assessment with Cognivue Clarity®: Psychometric Properties and Normative Ranges in a Diverse Population
James E. Galvin, Lun‐Ching Chang, Paul W. Estes, et al.
Journal of Alzheimer s Disease (2024) Vol. 100, Iss. 2, pp. 509-523
Open Access | Times Cited: 4
James E. Galvin, Lun‐Ching Chang, Paul W. Estes, et al.
Journal of Alzheimer s Disease (2024) Vol. 100, Iss. 2, pp. 509-523
Open Access | Times Cited: 4
Digital Clock and Recall: a digital, process-driven evolution of the Mini-Cog
Joyce Gomes‐Osman, Soo Borson, Claudio Toro‐Serey, et al.
Frontiers in Human Neuroscience (2024) Vol. 18
Open Access | Times Cited: 4
Joyce Gomes‐Osman, Soo Borson, Claudio Toro‐Serey, et al.
Frontiers in Human Neuroscience (2024) Vol. 18
Open Access | Times Cited: 4
Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability
Joseph Therriault, Shorena Janelidze, Andréa Lessa Benedet, et al.
Nature Aging (2024) Vol. 4, Iss. 11, pp. 1529-1537
Open Access | Times Cited: 4
Joseph Therriault, Shorena Janelidze, Andréa Lessa Benedet, et al.
Nature Aging (2024) Vol. 4, Iss. 11, pp. 1529-1537
Open Access | Times Cited: 4
Plasma p‐tau217 concordance with amyloid PET among ethnically diverse older adults
Breton M. Asken, Jesse C. DeSimone, Wei‐en Wang, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2024) Vol. 16, Iss. 3
Open Access | Times Cited: 2
Breton M. Asken, Jesse C. DeSimone, Wei‐en Wang, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2024) Vol. 16, Iss. 3
Open Access | Times Cited: 2
Baseline levels and longitudinal changes in plasma Aβ42/40 among Black and white individuals
Chengjie Xiong, Jingqin Luo, David A. Wolk, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Chengjie Xiong, Jingqin Luo, David A. Wolk, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
P-tau217 as a Reliable Blood-Based Marker of Alzheimer’s Disease
Roy Lai, Brenden Li, Ram Bishnoi
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1836-1836
Open Access | Times Cited: 1
Roy Lai, Brenden Li, Ram Bishnoi
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1836-1836
Open Access | Times Cited: 1
Cognivue Clarity characterizes mild cognitive impairment and Alzheimer’s disease in biomarker confirmed cohorts in the Bio-Hermes Study
James E. Galvin, Michael J. Kleiman, Paul W. Estes, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
James E. Galvin, Michael J. Kleiman, Paul W. Estes, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
COGNITIVE ASSESSMENT WITH COGNIVUECLARITY®: PSYCHOMETRIC PROPERTIES AND ENHANCED NORMATIVE RANGES IN A DIVERSE POPULATION
James E. Galvin, Lun‐Ching Chang, Paul W. Estes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
James E. Galvin, Lun‐Ching Chang, Paul W. Estes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Characterization of Ptau181 Among a Diverse Community-Based Cohort: A HABS-HD Study
Melissa Petersen, Fan Zhang, James Hall, et al.
Journal of Alzheimer s Disease (2024) Vol. 100, Iss. s1, pp. S63-S73
Closed Access
Melissa Petersen, Fan Zhang, James Hall, et al.
Journal of Alzheimer s Disease (2024) Vol. 100, Iss. s1, pp. S63-S73
Closed Access
Cognivue Clarity ® Characterizes Mild Cognitive Impairment and Alzheimer’s Disease in Biomarker Confirmed Cohorts in the Bio-Hermes Study
James E. Galvin, Michael J. Kleiman, Paul W. Estes, et al.
Research Square (Research Square) (2024)
Closed Access
James E. Galvin, Michael J. Kleiman, Paul W. Estes, et al.
Research Square (Research Square) (2024)
Closed Access
Analytical and Clinical Validation of a High Accuracy Fully Automated Digital Immunoassay for Plasma Phospho-Tau 217 for Clinical Use in Detecting Amyloid Pathology
David Wilson, Meenakshi Khare, Gallen Triana‐Baltzer, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
David Wilson, Meenakshi Khare, Gallen Triana‐Baltzer, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Preliminary reference values for Alzheimer’s disease plasma biomarkers in Congolese individuals with and without dementia
Jean Ikanga, Kharine Jean, Priscilla Medina, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access
Jean Ikanga, Kharine Jean, Priscilla Medina, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access
Diagnostic accuracy of phosphorylated tau217 in detecting Alzheimer's disease pathology among cognitively impaired and unimpaired: A systematic review and meta‐analysis
Mohammad Khalafi, William Jones Dartora, Laura Beth McIntire, et al.
Alzheimer s & Dementia (2024)
Open Access
Mohammad Khalafi, William Jones Dartora, Laura Beth McIntire, et al.
Alzheimer s & Dementia (2024)
Open Access
